Early-Onset Leptomeningeal Manifestation of G47R Hereditary Transthyretin Amyloidosis.
作者信息
Cechin Laura, Gasmelseed Jihad, Bashford James, Rowczenio Dorota, Reilly Mary M, Gillmore Julian D, Coutinho Ester
机构信息
King's College Hospital (LC, JG, JB, EC), London; National Amyloidosis Centre (DR, JDG), Centre for Amyloidosis & Acute Phase Proteins, Division of Medicine, University College London; and Centre for Neuromuscular Diseases (MMR), UCL Queen Square Institute of Neurology, United Kingdom.
出版信息
Neurol Clin Pract. 2021 Oct;11(5):e757-e759. doi: 10.1212/CPJ.0000000000001054.
Abstract
摘要
相似文献
1
Early-Onset Leptomeningeal Manifestation of G47R Hereditary Transthyretin Amyloidosis.G47R遗传性转甲状腺素蛋白淀粉样变性的早发性软脑膜表现
Neurol Clin Pract. 2021 Oct;11(5):e757-e759. doi: 10.1212/CPJ.0000000000001054.
2
Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.神经胶质细胞可减弱转甲状腺素蛋白G47R在中枢神经系统中蓄积的证据。
Neuropathology. 2018 Feb;38(1):11-21. doi: 10.1111/neup.12412. Epub 2017 Sep 28.
3
A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.一种与柔脑膜淀粉样变性相关的新型甲状腺素转运蛋白第49位苏氨酸突变为脯氨酸的基因突变。
J Neurol Sci. 2008 Sep 15;272(1-2):186-90. doi: 10.1016/j.jns.2008.05.014. Epub 2008 Jun 24.
4
Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.遗传性转甲状腺素淀粉样变性病的胃肠功能障碍的诊断与治疗。
Clin Auton Res. 2019 Sep;29(Suppl 1):55-63. doi: 10.1007/s10286-019-00628-6. Epub 2019 Aug 26.
5
THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.THAOS：转甲状腺素蛋白淀粉样变性的胃肠道表现——一种罕见疾病的常见并发症
Orphanet J Rare Dis. 2014 Apr 27;9:61. doi: 10.1186/1750-1172-9-61.
6
[An autopsy case of leptomeningeal amyloidosis associated with transthyretin Gly47Arg mutation].
Rinsho Shinkeigaku. 2016 Nov 29;56(11):777-780. doi: 10.5692/clinicalneurol.cn-000911. Epub 2016 Oct 26.
7
Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.遗传性转甲状腺素蛋白淀粉样变性多发性神经病患者的健康相关生活质量：一项前瞻性观察研究。
Orphanet J Rare Dis. 2020 Mar 6;15(1):67. doi: 10.1186/s13023-020-1340-x.
8
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).来自转甲状腺素蛋白淀粉样变预后调查（THAOS）的晚发性与早发性Val30Met转甲状腺素蛋白淀粉样变患者的特征。
Neurol Ther. 2021 Dec;10(2):753-766. doi: 10.1007/s40120-021-00258-z. Epub 2021 May 22.
9
Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China.中国遗传性转甲状腺素蛋白淀粉样变性患者的临床表型和遗传特征。
Orphanet J Rare Dis. 2022 Sep 2;17(1):337. doi: 10.1186/s13023-022-02481-9.
10
Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis.导致遗传性软脑膜淀粉样变性的变异甲状腺素运载蛋白的生化特征。
Amyloid. 2005 Dec;12(4):216-25. doi: 10.1080/13506120500352404.
引用本文的文献
1
Effects of Tafamidis Meglumine on Transient Focal Neurological Episodes and Meningeal Contrast Enhancement in Hereditary Transthyretin-Related Meningeal Amyloidosis: Report of Two Patients Carrying the c.265T>C (p.Y89H) Variant.葡甲胺氯苯吩嗪对遗传性转甲状腺素蛋白相关脑膜淀粉样变性中短暂性局灶性神经发作和脑膜对比增强的影响：两例携带c.265T>C（p.Y89H）变异患者的报告
Brain Behav. 2025 Sep;15(9):e70856. doi: 10.1002/brb3.70856.
2
Cognitive manifestations and brain integrity in hereditary transthyretin amyloidosis: a systematic review.遗传性转甲状腺素蛋白淀粉样变性的认知表现与脑完整性：一项系统综述
J Neurol. 2025 May 25;272(6):419. doi: 10.1007/s00415-025-13120-1.
3
Hereditary leptomeningeal transthyretin amyloidosis with heterozygous TTR mutation: a case report and literature review.伴有杂合性甲状腺素转运蛋白（TTR）突变的遗传性软脑膜转甲状腺素蛋白淀粉样变性：一例报告及文献综述
Orphanet J Rare Dis. 2025 May 5;20(1):213. doi: 10.1186/s13023-025-03736-x.
本文引用的文献
1
Advances in the treatment of hereditary transthyretin amyloidosis: A review.遗传性转甲状腺素蛋白淀粉样变性病治疗的进展：综述。
Brain Behav. 2019 Sep;9(9):e01371. doi: 10.1002/brb3.1371. Epub 2019 Aug 1.
2
Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.遗传性 ATTRV30M（p.TTRV50M）淀粉样变性患者口服塔法米迪治疗时脑脊液和玻璃体中的暴露情况。
Amyloid. 2018 Jun;25(2):120-128. doi: 10.1080/13506129.2018.1479249. Epub 2018 Jul 11.
3
Extremely early onset hereditary ATTR amyloidosis with G47R (p.G67R) mutation.伴有G47R（p.G67R）突变的极早发型遗传性转甲状腺素蛋白淀粉样变性
Amyloid. 2016 Sep;23(3):205-206. doi: 10.1080/13506129.2016.1185410. Epub 2016 May 20.
4
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.非活检诊断心脏转甲状腺素淀粉样变性。
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.
5
Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.转甲状腺素蛋白（ATTR）淀粉样变性：临床谱、分子发病机制和疾病修饰治疗。
J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):1036-43. doi: 10.1136/jnnp-2014-308724. Epub 2015 Jan 20.
6
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.一名非洲患者中与转甲状腺素蛋白Leu12Pro相关的眼软脑膜淀粉样变性
J Neurol. 2015 Jan;262(1):228-34. doi: 10.1007/s00415-014-7594-2. Epub 2014 Dec 9.
7
The biological and chemical basis for tissue-selective amyloid disease.组织选择性淀粉样变性疾病的生物学和化学基础。
Cell. 2005 Apr 8;121(1):73-85. doi: 10.1016/j.cell.2005.01.018.
8
Mutation and transcription analysis of transthyretin gene in Italian families with hereditary amyloidosis: a putative novel hot spot' in codon 47.意大利遗传性淀粉样变性家族中转甲状腺素蛋白基因的突变与转录分析：密码子47处一个假定的新热点
Clin Genet. 2000 Apr;57(4):284-90. doi: 10.1034/j.1399-0004.2000.570407.x.
Zotero 插件